Dario Amodei, CEO of Anthropic, highlighted a significant concern regarding AI firms: they have yet to fulfill their ambitious promises to benefit the world. He linked the public's skepticism towards technology to what he termed a "fundamental crisis of trust."
1/2 Thanks Gavin for an especially thoughtful exchange. I don't usually spend much time on social media but I wanted to engage here because it really brings out the heart of an important conversation.
First, on regulation, I think that “either concentrate it in the hands of a… https://t.co/2W6vWJAE8Y
— Dario Amodei (@DarioAmodei) August 15, 2026
This statement was a response to investor Gavin Baker, who criticized Amodei for his overly negative rhetoric and urged him to promote the benefits of artificial intelligence more actively. Amodei contended that marketing alone cannot alter public perception; rather, the industry must demonstrate tangible results instead of making grand claims about AI curing cancer.
The Debate on Trust in AI
Baker argued that Amodei had "lost the debate" on AI regulation and should adopt a more positive stance as he is poised to become the CEO of a major public company. In response, Amodei shared a series of posts on X, noting that he typically does not engage much on social media but felt compelled to participate due to the importance of the discussion.
Amodei stated that he considers both the risks and benefits of technology equally. As a positive example, he referenced the essay "Machines of Loving Grace," which explores the potential impacts of powerful AI on healthcare, the economy, and quality of life.
However, he acknowledged the existence of public distrust towards AI:
"I think it stems from a fundamental crisis of trust. Ordinary people do not trust companies, governments, or the tech industry and always suspect that we are devising new ways to deceive them."
According to him, this distrust has developed over decades, with AI being just the latest manifestation of it.
"The Responsibility is Ours"
Amodei accepted that the AI industry itself bears responsibility. He pointed out that a valid criticism of companies like Anthropic is that they have yet to deliver on their significant promises to contribute positively to society.
"This is entirely on us. I think this is what we should be criticized for, not for all these things related to messaging and marketing," wrote the Anthropic CEO.
He emphasized that a new advertising campaign would not rectify the situation, as claims about AI curing cancer have become clichés and are viewed by many as deceptive.
"Only one thing will work — actually curing cancer," Amodei stressed.
He added that the company plans to enhance its efforts in biology and medicine, asserting that "incredible results" could be achievable in the coming years, although he did not specify what those results would entail.
Emphasis on Openness
Not everyone agrees with Amodei's perspective. AI researcher Yann LeCun responded, arguing that for nearly a decade, he has maintained that the only viable path forward is to develop AI technologies that are widely accessible, shared, and open.
For about 10 years now, I have argued that the *only* way forward is for AI technology to be widely available, shared, and open.
— Yann LeCun (@ylecun) August 16, 2026
Like the printing press and the Internet, AI amplifies human intelligence and efficiency by improving access to knowledge.
To empower individuals,…
He noted that AI, similar to the printing press and the internet, enhances human capabilities by broadening access to knowledge.
"We need diverse AIs for the same reason we need a diverse press," LeCun wrote.
He also referenced Mark Zuckerberg's stance that the notion of AI being so dangerous that the only safe option is extreme power concentration is problematic.
This view contrasts with Anthropic's policy regarding the most powerful systems. While the company does not advocate a complete ban on models with open weights as a class, it believes that safety requirements should increase as their capabilities grow.
OpenAI's GTM specialist, Angel Brodin, also voiced a differing opinion, as reported by Business Insider. She pointed out that real achievements in medicine do not prevent the pharmaceutical industry from being one of the sectors with low public trust.
She argued that the perception of AI companies will depend not only on technological outcomes but also on product accessibility, pricing, lobbying, transparency, and the distribution of economic benefits.
Previously, ForkLog compiled a list of intriguing projects demonstrating how distributed databases and AI are addressing practical challenges well beyond the financial sector.